Autoimmune Diseases

Autoimmune Diseases

Medpace has experience conducting global Phase I-IV trials across a spectrum of Autoimmune Diseases.

The Medpace Difference for Clinical Research in Autoimmune Diseases

  • Global experience covering countries and regions with high incidences of disease
  • Experience working with Sponsors developing biosimilars, combination therapies, and new approaches
  • Strong relationships with key industry investigative sites and Key Opinion Leaders (KOLs) who specialize in recruiting patients
  • Global central lab with safety and biomarker validation and analysis
  • Imaging Core Lab brings expertise to support endpoints for autoimmune disease studies – a combination of imaging expertise and clinical trial experience ensures that imaging components are seamlessly integrated into the complex structure of the overall trial
  • In-house medical expertise in related therapeutic areas provides additional support and insights
  • Strong experience in rare disease/orphan indications and pediatric trials provides a depth of resources and expertise